Bindong Liu is an Associate Professor in Center for AIDS Health Disparities Research School of Medicine at Meharry Medical College USA. He earned his PhD at Jilin University China. He is a member of American Society for Microbiology and the American Association for the Advancement of Science. He served as a reviewer of peer reviewed journals in the area of microbiology and immunology. His research focuses on the interaction between HIV1 and host restriction factors

His research focuses on the interaction between HIV-1 and host restriction factors

Hua Zhu is an Associate Professor of Department of Microbiology and Molecular Genetics, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Adjunct Professor Xiamen University China. He has received a PhD in Philosophy from the Columbia University New York NY in 1993. He received "John S Newberry Prize" for the most promising student of the year Department of Biological Sciences Columbia University. He has completed his postdoctoral training in herpesviruses in Princeton University New Jersey NJ 1993-98. He received two Gall Award New Jersey Cancer Research Award for Scientific Excellence 19961008. He was named as American Cancer Society Research Scholar. He is serving as an editorial board member of reputed journals and reviewer of 6 journals. He published 40 research articles reviews and book chapters

Human cytomegalovirus gene expression and regulation, Human cytomegalovirus pathogenesis, Varicella Zoster virus pathogenesis, Animal models for herpesvirus studies, Vaccine development against herpesviruses

Qianjun Li Ph D is a faculty member at Division of Infectious Diseases in Department of Medicine, The University of Alabama at Birmingham, USA. He earned his PhD at Beijing Agricultural University Beijing, China. Currently he is an assistant professor and Adjunct Professor in Department of Microbiology at The University of Alabama at Birmingham. He has published several reviewed papers He has teaching experience of more than 10 years. He was one of the members in American Society of Virology the America Society of Tropical Medicine and Hygiene the International Society of Antiviral Research. He served as a reviewer of peer reviewed journals in the area of antiviral research, Clinical and Experimental Medicine, Medical Entomology, Insect Molecular Biology as well as an ad hoc member in various NIH Peer Review Committees

Virology/Vaccine, Tropical Infectious Diseases/International Medicine

Honglin Zhou is Associate Director, Center for Resuscitation Science, Hospital of the University of Pennsylvania, Translational Research Laboratory, USA

Retrovirology & Drug Metabolism

Limin Chen is a lab manager and research scientist in the Faculty of Medicine at the University of Toronto. He has received a PhD in Molecular Genetics from the University of Toronto 2005. He has completed his MD in China 1987 and received a MSc degree in Cancer Biochemistry and Molecular Biology from Sichuan University, China 1990. He received World Health Organization WHO Fellowship and Fellowships from National CIHR Research Training Program in Hepatitis C (NCRTPHepC) and Canadian Institutes of Health Research (CIHR). He is one of the members in Canadian Association for Studying of liver diseases CASL. He received many awards such as the Gold Prize from the 3rd international conference in infectious disease 2009 and Best research Award CASL 2006. He is serving as an editorial board member of reputed journals and reviewer of 4 highprofile journals. He has published more than 20 papers so far with one pioneer paper has been cited over 110 times

Infectious diseases, Hepatitis C virus infection, Molecular mechanism of treatment resistance, High-throughput screening, Microarray and gene expression profiling, Personalized medicine, Predicting treatment response, Novel anti-viral drug development

I am currently an assistant professor at Monash University, School of Medicine and Health Sciences. I am particularly interested in the research areas of antiviral development and viral immune evasion. During the past six years I have been conducting research into the recently emerged Hendra and Nipah viruses, both novel zoonotic agents with no effective therapeutics. Their classification as Biological Safety Level 4 (BSL4) pathogens, and their inclusion as National Institute of Allergy and Infectious Diseases (NIAID) Category C priority pathogens make novel antiviral drug development a high priority and this has been the core of my recent research.

Antiviral development and viral immune evasion

Prof. Shahzad is currently affiliated with University of Vienna, Austria. Prof. Shahzad is one of the pioneers, working for the progress of translational medicine field. He is serving as a secretary general and director of administration for “international society for translational medicine (ISTM)”. He is serving as visiting professor of translational medicine, at the First Affiliated Hospital, Harbin Medical University, Harbin, China. He is also appointed as associate professor of translational medicine (Adj), at the First Affiliated Hospital, Wenzhou Medical College, China. Prof. Shahzad has won many prestigious international fellowships and awards. Prof. Shahzad is invited speaker for many international life sciences conferences.

Translational Research and Clinical Diagnostics

Dr. Shan Cen is a Professor and Head of Immunology Division at the Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Pekin Union Medical College, China, Project director, Lady Davis Institute for Medical Research, Jewish General Hospital Canada, Adjunct Assistant Professor Department of Microbiology, McGill University, Canada, Adjunct Faculty member Department of Medicine McGill University, Canada. He has received a PhD degree in Microbiology from Chinese Academy of Preventive Medicine in 1994. He has completed his MS in Microbiological Medicine Inst of Medicinal Biotechnology Chinese Academy of Medical Science, China, and he also completed BSc from the Department of Microbiology Shandong University, China. Dr Shan Cen has been serving as a reviewer for reputed journals including J Biol Chem J Virol PlosOne Virology Retrovirology for years

Virus-host interaction, Host restriction factor, Viral assembly, Reverse transcription, Novel antiviral target, Establishment and validation of drug screening assay, HIV, HCV, Influenza, EV71

Nicolas Sluis Cremer PhD is Director of Basic Research in the Division of Infectious Diseases and an Assistant Professor of Medicine. Dr Sluis Cremer research focuses on antiretroviral drugs drug resistance and HIV latency Projects include understanding the biochemistry and cellular biology of HIV reverse transcription elucidating the mechanisms of action and resistance to HIV antiviral drugs and the discovery of novel inhibitors active against drug resistant HIV1. New initiatives include understanding the mechanisms involved in HIV latency and pharmacological approaches to eradicate latent HIV infection

Biochemistry and cellular biology of HIV reverse transcription Mechanisms of HIV drug resistance Discovery of inhibitors active against drug resistant HIV-1 Pharmacological approaches to eradicate latent HIV

Guangxiang George Luo is currently professor Department of Microbiology Immunology and Molecular Genetics, University of Kentucky College of Medicine visiting professor at Peking University, Health Science Center and guest professor, Central South University, Changsha, China and Beijing, China. He graduated from Hunan Medical University and had received postdoctoral training at Fox Chase Cancer Center in Philadelphia and Mount Sinai School of Medicine in New York. He serves as a member of the editorial boards of Journal of Virology, Virologica Sinica and other scientific journals

The major research interest of my laboratory is centered on the molecular genetic analysis of HCV replication, virus-host interaction, and molecular pathogenesis. Our overall objective is to combine reverse genetic, biochemical, cell biological, proteomic, and transgenic approaches to a thorough understanding of the molecular mechanisms of HCV RNA expression, replication, virion assembly, and viral pathogenesis.

Dr Reitz obtained his PhD in 1970 from the Department of Biochemistry at Purdue University. His graduate work in the field of enzymology was supervised by Professor Victor Rodwell a recognized scholar in studies of enzymes of amino acid catabolism. Dr Reitz trained as a postdoctoral fellow at the Boston Biomedical Research Institute in the laboratory of Dr Rao Sanadi in the field of tRNA and tRNA aminoacyl synthetases. He was recruited as a staff scientist to Bionetics Research Laboratory in 1971 as part of the laboratory group of Dr Robert Gallo and joined him at NIH in 1976. He received tenure in 1984 became Head of the Molecular Biology of Hematopoietic Cells Section in 1992 and Acting Chief of the Laboratory of Tumor Cell Biology in 1995 when Dr Gallo left to found the IHV Dr Reitz was recruited to the IHV as a tenure track Associate Professor and Associate Director of the Basic Science Division in February 1996 and became Professor with full tenure in 1998. His expertise is in the fields of molecular biology and virology especially retroviruses and herpesviruses. He is focused on host cellvirus interactions and their effects on immunopathology and carcinogenesis at the level of regulation of signaling and gene expression

Molecular biology and virology, especially retroviruses and herpesviruses. Host cell-virus interactions and their effects on immunopathology and carcinogenesis at the level of regulation of signaling and gene expression.

Dr. Shou-Jiang SJ Gao is the HEB Distinguished Chair for Cancer Research, a Professor in the Departments of Pediatrics Microbiology and Immunology Molecular Medicine and Medicine and the Leader of Tumor Virology Program at the Greehey Childrens Cancer Research Institute at The University of Texas Health Science Center at San Antonio, Texas, USA. He earned his PhD at the University of Bordeaux Bordeaux France and received Postdoctoral training at the University of Massachusetts at Amherst Massachusetts and Columbia University in New York, New York. He has published over 90 peerreviewed papers as well as several reviews and book chapters. He has over more than 15 years of teaching experiences. He is member of the American Society of Microbiology and several other professional organizations. He has served on the Editorial Boards for several peerreviewed journals and as a reviewer for over 30 peer reviewed journals in the area of Microbiology and Cancer Biology. He has served on grant review panels for National Institute of Health and several other Federal Organizations and private foundations. He has organized or co-organized several international conferences. He received many awards like American Cancer Society, Research Scholar Award and American Society of Microbiology ICAAC Outstanding Young Investigator Award

Cancer Biology, Infectious Diseases, and HIV/AIDS

Dr Garzino Demo received his PhD at the University of Torino, Italy in 1988. Between 1989 and 1991 he conducted research examining the effect of co-factors such as HHV6 on the progression of HIV infection. From 1991 until 1996 Dr Garzino Demo worked with Dr Robert C Gallo at the Laboratory of Tumor Cell Biology at NCI, NIH. Continuing his studies on cofactors in HIV infection and on HIV gene expression Dr Garzino Demo joined the Institute of Human Virology in January 1996 to further his studies on HIV suppressive factors produced by the immune system. He was a member of the team that originally identified RANTES MIP1a and MIP1ß as suppressive HIV suppressive factors in 1995. Successively he participated to the characterization of another chemokine MDC with broad HIV suppressive activity In addition he has been the key investigator in a large study of antigen induced chemokine release in a well characterized adult cohort MACS cohort. He is also the author of several other scientific publications and reviews on chemokines their role in HIV infection and their regulation. The main focus of his research is on the role of host factors in controlling HIV infection. Recently he and his laboratory have described the HIV inhibitory activity of betadefensins demonstrating that hBD2 inhibits HIV through a novel antiviral mechanism mediated by a chemokine receptor CCR6 that induces increased expression of the antiviral protein APOBEC3G. These findings are of importance in mucosal immunity and HIV infection.

HIV, AIDS pathogenesis, Host factor that limit HIV infection, Innate immunity, Mucosal immunity, Chemokines, Defensins, Intracellular signaling, Viral oncology

Dr Xu currently serves as Director of Medicinal Chemistry / Associate professor at the Institute for Hepatitis and Virus Research IHVR which was created by The Hepatitis B Foundation. He is President of Enantigen Therapeutics Inc a spinoff company of the IHVR which focuses on the development of oral therapeutics for the treatment of viral related diseases such as HBV and HCV microbial infections including MDR pathogens and DENV at the Pennsylvania Biotechnology Center. Dr Xu is also Cofounder of Pharmabridge Inc Prior to joining IHVR. He was a medicinal chemist at Antimicrobial Agents Research Team at Johnson Johnson Pharmaceutical Research Development LLC. Dr Xu completed his PhD at New York University where he studied enantiosensors for chiral recognition

Drug Discovery and Development, Structure Activity Relationship Study, Lead Optimization, Hepatitis B, Hepatitis C, Dengue Virus Infection, MDR pathogens

Shixin Liu is a Howard Hughes Medical Institute Postdoctoral Research Associate at University of California Berkeley. He has received a PhD degree in chemistry from Harvard University in 2009. He has completed his BS in biology in University of Science and Technology of China. He received Chinese Government Award for Outstanding Student Abroad in 2008. He is a member of American Chemical Society and Biophysical Society

Using single-molecule manipulation and detection tools to study the molecular mechanisms of complex biological processes.

Sita Awasthi is a Research Assistant Professor in the Department of Medicine Infectious Disease Division at University of Pennsylvania, Philadelphia PA, USA. She earned her PhD from Devi Ahilya University Indore India. She has published over 20 peer reviewed papers and was coauthor of book chapters and reports. She was the president of Association of Women in Science AWIS Philadelphia chapter. She is an active members of International Society of Vaccines. She served as a reviewer of peer reviewed journals in the area of vaccine and Virology

Vaccine development against infectious disease in general, Pre clinical development of vaccine against HSV-2 and HSV-1, Spread and pathogenesis of HSV-1/HSV-2, Evasion of host immunity by viruses, HSV-2-HIV co-infection.

Srinivas Odde is Postdoctoral Research Associate, Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, USA

Pharmacology and Pharmaceutical Sciences

Kai Lin is Group Head (HCV) Infectious Diseases, Virology Novartis Institutes for BioMedical Research Inc., Senior Research Investigator, USA

Virology, Biomedical Research

Dr. Desai obtained her Bachelor of Science and Master of Science in Biochemistry from University of Bombay in 1981 and 1983 respectively. She received her Doctorate in Biochemistry from the University of Bombay in 1991. From 1991 to 1996 Dr Desai did a postdoctoral fellowship at the UMDNJ Robert Wood Johnson Medical School in New Jersey. Since 1996 she was a faculty member in the Department of Pharmacology at the UMDNJ/RWJMS. During her tenure there she made a novel finding that ISG15 a UBL is overexpressed in many tumor cells and its over expression interferes with protein polyubiquitination and degradation. She also worked on the repair of topoisomerase I TOP1 mediated DNA damage. She showed that one of the repair mechanisms for TOP1 DNA covalent complexes is through the activation of the ubiquitin/26S proteasome pathway. This novel repair mechanism is quite significant and may have implications in the resistance mechanism to the clinically used TOP1 directed anticancer drugs eg Toptecan In 2007. Dr Desai joined the LSU HSC as Assistant Professor in the Department of Biochemistry Molecular Biology.

The roles of ubiquitin and ubiquitin-like proteins in cancer, Mechanism of tumor cell death and drug resistance. The roles of ubiquitin and ubiquitin-like protein ISG15 in neurodegenerative diseases.

Jingdong Tian holds joint appointment in the Department of Biomedical Engineering and the Institute for Genome Sciences and Policy at Duke University and Medical School Durham NC USA. He earned his PhD at the State University of New York at Stony Brook Long Island and received his postdoctoral training at Harvard Medical School Boston MA. He also serves as an Adjunct Professor in the Chinese Academy of Sciences. He published over 25 peered reviewed papers and book chapters. He has been teaching biomedical engineering and genome sciences for more than 5 years. He is a member of the Biomedical Engineering Society the American Chemical Society and the American Society of Cell Biology. He served as a reviewer of over 20 peer reviewed journals in the areas of nanomedicine, biomolecular engineering and synthetic biology. He received a number of prestigious awards like the LSRF Postdoctoral Fellowship the Beckman Young Investigator Award and the Hartwell Foundation Individual Biomedical Research Award.

Vaccine development for emerging infectious diseases, DNA vaccine design and optimization, viral genome synthesis, synthetic biology and drug delivery.

Sandeep Mukherjee is an Associate Professor of Internal Medicine Section of Gastroenterology and Hepatology, University of Nebraska Medical Center UNCM Omaha, Nebraska Staff, Gastroenterologist Section of Gastroenterology, Omaha, Veterans Affairs Medical Center, Omaha Nebraska. He received his medical degree MB;BCh from the University of Wales, College of Medicine in 1991 and completed training in Internal Medicine Gastroenterology and Liver Transplantation in the United Kingdom and the United States. He has been on faculty at UNMC since 2000 and was Chief of the Section of Gastroenterology at Omaha VAMC from 2005-2008. He is on an editorial board member of 9 journals and reviewer of 13 journals. He has published 57 abstracts 72 peer reviewed articles authored or coauthored 4 book chapters and is the editor of the book Hepatitis C and Liver Transplantation

Viral hepatitis (pre- and post-liver transplant), Fatty liver disease, Endoscopy, Liver transplantation

Virus infection and host innate immune responses, focusing on how virus infection regulates dendritic cell maturation and contributes to viral pathogenesis. Herpes simplex virus 1 (HSV-1) recombinant virus vaccine vector. HSV-1 ICP34.5 deletion mutant virus has been discovered as a vaccine vector, I am interesting on developing vector based viral vaccine, such as HSV-1, HSV-2, HIV-1 vaccine.

Virology, Microbiology, Biochemistry, Metabolism, Metabolomics, and Proteomics

 

Kozo Fujisaki is a Professor of Laboratory of Emerging Infectious Diseases, Department of Frontier Veterinary Medicine, Kagoshima University Kagoshima, Japan. Professor of Molecular Epidemiology of Emerging Infectious Diseases Course of Pathological and Preventive Veterinary Science, United Graduate School of Veterinary Science, Yamaguchi University, Yamaguchi, Japan. Visiting Professor of Molecular Arthropodology National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan. Honorary Professor Mongolian State, University of Agriculture, Ulaanbaatar Mongolia, Adjunct Member of Institute of Arthropodology and Parasitology Georgia Southern University Statesboro GA USA. He has received a PhD in Agriculture from Osaka Prefectural University Osaka Japan 1979. He has completed his BA in Veterinary Medicine in Kagoshima University Kagoshima Japan 1969. He received the Japanese Society of Veterinary Science Award in 1979 and the Japanese Society of Parasitology "Katsurada" Award in 2010. He is serving as an editorial board member of reputed journals and reviewer Number of publications is nearly 270

1. Identification and characterization of tick bioactive molecules involved in blood-meal digestion and innate immunity against tick-borne zoonotic pathogens. 2. Molecular epidemiology of tick-borne zoonotic diseases. 3. RNAi silencing and its application for vector arthropod control. 4. Biology of Ectoparasites in Animals. 5. Molecular Biology of Ectoparasites in Animals. 6. Biology of Protozoan Diseases, Theileriosis and Babesiosis, Transmitted by Ticks

Dr. Kunihiro Kaihatsu is the assistant professor in Department of Organic Fine Chemistry Osaka University Japan. He earned his PhD at Kobe University Japan. He has published twenty of reviewed papers and a book chapter. He has been teaching experience of more than 6 years. He was one of the members in International Society of Antiviral Research, The Japanese Society for Virology, The Chemical Society of Japan, The Pharmaceutical Society of Japan and Japanese Society of Catechinology. He served as a reviewer of peer reviewed journals in the area of biological chemistry. He received many awards like Biobusiness Competition Japan Award in 2009 and 2010

Research interest is the inhibition of virus infection using catechin derivatives and non-natural nucleic acids and the diagnosis of infectious diseases using peptide nucleic acid (PNA) technology.

Dr. Honglin Luo is an Associate Professor in the Department of Pathology and Laboratory Medicine/James, Hogg Research Center at the University of British Columbia, Canada. Dr Luo completed her MSc and MD training in China. She then pursued her postdoctoral training at the University of Washington from 1997 to 2000. Dr Luo received a New Investigator Award from the Canadian Institutes of Health Research and a Scholar Award from the Michael Smith Foundation for Health Research. Dr Luo is at the leadingedge in her field of enteroviral infection. The objective of Dr Luo research is to define the signaling mechanisms of viral infection pathogenetic determinants of virushost interactions and host and viral genetics in enterovirus induced heart disease aiming to find out new antiviral strategies. She has published over 60 refereed papers and 6 book chapters. Most of these publications have been appeared in leading journals including Journal of Virology, Cell Death and Differentiation, Journal of Biological Chemistry, American Journal of Pathology and Circulation Research. Her research was supported by different grant agencies including the Canadian Institutes of Health Research the Heart Stroke Foundation of Canada the Canada Foundation for Innovation and the Hospital for Sick Kids Foundation

Signaling Mechanisms of Viral infections and Viral Genetics

Jonathan P Wong is a research scientist at Biotechnology Section Defence Research and Development Canada Suffield DRDC Suffield Ralston Alberta Canada He had completed both undergraduate and graduate studies in Biochemistry 1979, 1985 at University of Saskatchewan, Saskatoon Saskatchewan, Canada. He is serving as the editorial board member for 4 journals and as an adhoc reviewer for about 10 journals. He has published over 100 scientific papers book chapters technical reports and patents

Antimicrobial drug and vaccine development, Liposome drug delivery systems, Aerosol inhalation technologies, Animal infection models, Pathogenesis of microbial infections, Nucleic acid-based drugs, Immunology and immunomodulators, Influenza virus infections.

Ling PENG CNRS Research Director in CINaM UPR France

Functional Dendrimers for Nucleic Acid Delivery,Triazole Nucleoside Chemistry for Drug Discovery, Molecular Probes and Chemical Biology

Dr Hongzhou Lu is the director in the Department of Infectious Diseases Shanghai Public Health Clinical Center affiliated to Fudan University Shanghai China and the director of Shanghai HIV/AIDS diagnostic and treatment center. He earned his PhD at Shanghai Medical University China. Currently he is the Professor in Fudan University. He has published more than 100 reviewed papers and he was author of 3 books. He is also an expert consultant of The Ministry of Health for HIV/AIDS China and a member of Chinese Society of Infectious Disease and American Infectious disease and AIDS Society. He served as a reviewer of peerreviewed journals in the area of infectious diseases. He organized the Clinical Microbiology AIDS Opportunistic Infection Symposium. He received many awards like The Second Prize of Shanghai Scientific Technical Achievement The 10th Silver Snake Advanced Worker and Mingzhi Dairy Industry Life Science Prize Shanghai Science Technique Committee

Dr. Lua research mainly focuses on HIV/AIDS and its ossociated opportunistic infections. He also do some reseach on emerging infectious disease including H1N1 influnenza.

Dr. Zhiwei Chen has been the Director of AIDS Institute at the University of Hong Kong Li Ka Shing Faculty of Medicine since 2007. He received his PhD from the New York University in 1996. He then became a postdoctoral fellow a research scientist and subsequently a Staff Investigator and an Aaron Diamond Assistant Professor at the Aaron Diamond AIDS Research Center of the Rockefeller University. His research work defined the origin of HIV2 in feral sooty mangabeys and CCR5 as the dominant entry coreceptor of various non human primate lentiviruses. He was a guest professor at Wuhan University between 2003 and 2007 and has been a guest professor at the Chinese Academy of Medical Sciences since 2007 and at Nanjing University since 2009. Dr Chen has published over sixty research articles in peer reviewed international journals and currently serves as an editorial board member for three international journals. He is a member of the Advisory Council on AIDS appointed by the Government of the Hong Kong Special Administrative Region and an executive committee member of the China AIDS Vaccine Initiative CAVI. He was a recipient of research awards from the Charles H Revson/Norman and Rosita Winston Foundation and the American Foundation for AIDS Research

Dr. Chen current research interests include vaccine research for AIDS and other infectious diseases with a primary focus on mucosal vaccines for the prevention of HIV-1 sexual transmission. He is an inventor/co-inventor of two AIDS vaccines which have entered human trials in the United States. He is also interested in using new approaches to study mechanisms underlying AIDS pathogenesis.

Tao Peng is the Principal Investigator of Guangzhou Institute of Biomedicine and Health Chinese Academy of Sciences China. He earned his PhD at University of Pennsylvania Philadelphia USA. Currently he is the Head of Viral Immunology Laboratory and Adjunct Professor in University of Science and Technology of China. He is an enlisted scientist for "Hundred Talents Programme". He is the Chief Editor of the book "Isothermal Nucleic Acid Amplification Technology and Application". He is also an author of book chapters of "Molecular Gene Medicine" and "Platform Technologies in New Drug Discovery". He is the inventor of more than 10 patents. Dr Peng has many publications on peer reviewed journals

Through the understanding of virus-host interaction, to discover novel drug targets and to develop new antiviral screening assays.

Sai Ming Ngai is an associate professor in the Department of Biology of the Chinese University of Hong Kong in Hong Kong SAR China. He earned his PhD at the University of Alberta Edmonton Canada. Currently he is the core member of the State Key Laboratory for Agrobiotechnology Institute of Plant Molecular Biology and Agricultural Biotechnology. He is also the director of the Chinese Medicinal Fungal Proteomic Laboratory in the Chinese University of Hong Kong. He had published 46 Reviewed papers and was the author of two book chapters. He has more than ten years teaching experience. He served as a reviewer of peer reviewed journals like clinical chemistry molecular and cellular proteomics, proteomics, plant cell protein science and biochemistry

Proteomics and bioinformatics; protein/peptide structural and functional studies; viral and stem cell research; research and development on modern chinese medicine.

Yiguang Jin is Associate Professor in Department of Pharmaceutical Chemistry Beijing Institute of Radiation Medicine China. He earned his PhD at Peking University, Beijing. He has published 32 reviewed papers and he was the author of two chapters and one book. He has been teaching experience of more than 6 years He served as a member of American Chemical Society. He was one of the members in Chinese Pharmaceutical Association. He served as a reviewer of peer reviewed journals in the area of antivirals, cancer pharmacotherapy and pharmaceutics. He received many awards like Distinguished Youth Scientist of Beijing

Nanotechnology in antiviral drug delivery, Targeted drug delivery, Novel polymer for drug delivery.

Zhen Li PhD deputy director of Institute of Animal Science and Veterinary Medicine SAAS Shanghai Academy of Agricultural Sciences. His research is mainly focus on animal zoonotic disease and veterinary prevention. He is now cochairing five research projects including an international fund of research on porcine diarrhea virus. He had more than 60 publications on domestic as well as international journals such as Journal of Virology, Veterinary Microbiology and Virus Research. He is now advisor and promoter of graduated students in Nanjing Agricultural University and Shanghai Donghua University member of editorial board of Chinese Journal of Biotechnology and Journal of Microbiology. He is also Chairman of Shanghai Veterinary Public Health Association

Veterinary Microbiology and Virus Research

Jiatong Zhuo is a professor and deputy director of Guangxi Autonomous Region, Center for Disease Control and Prevention. He has spent most of his scientific carrier in the children vaccine preventable disease. Under his effort Guangxi autonomous region reached the goal of polio free in 2000. He created this new strategy to select high risk county with the interval of interepidemics of historic surveillance data and carrying mass campaign in the subtropic area after his finished his public health policy/management study in Emory in 1998 and make the measles controlled in the forefront of china as well as in the South east of Asia. Dr Zhuo was a founder of communicable disease and public health even emergency information delivery and administrative management networks system in Guangxi in 2001 and made the SARS very much timely controlled in the spring of 2003. Professor Jiatong Zhuo is the Adjunct Professor of Guangxi Medical University and also is the MPH advisor of Rollins School of Public Health Emory. He published about ten peer reviewed papers in Journal of Infectious Disease, Journal of Hepatology. He is the author of the book HIV/AIDS handbook for grassroot doctors and epidemiologist in China. He received Guangxi government highest award on his research for Yellow Card Warning System to Push Immunization Program in Guangxi and second level awards on his research for polio free in Guangxi and got the third level awards on his research for Yellow Card Warning System to Push Immunization Program in Guangxi from the Disease Prevention Society of China. Dr Zhuo is the Chinese State Council Special Stipend Award scientist and the member of Technical Advise Committee on Immunization of Health Ministry of China and the committee member of Chinese Vaccine and Immunization Society

Pathology, Hepatology and Virology

Wei Hua Yan is an Associate Professor and Director of the Medical Research Center Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical College China. He earned his PhD in Immunology at Shanghai Institute of Immunology Shanghai Second Medical University, Shanghai, China. He has published more than thirty international peer reviewed research papers and reviews. He served as a member of American Society for Histocompatibility and Immunogenetics Medical Association for Hematological Diseases of Zhejiang Province Society for Immunology of Zhejiang Province vice Director of Society for Clinical Immunology of Zhejiang Province, China. He served as a reviewer of peerreviewed journals in the area of cancer biology clinical immunology and immunogenetics. He received many awards like Distinguished Returned Overseas scholars of Zhejiang Province Zhejiang Provincial program for the cultivation of highlevel innovative health talents, China.

Human leukocyte antigen-G (HLA-G) is a potent immunosuppressive molecule by inducing functional silencing of both innate and adaptive immune responses. An increasing number of studies have highlighted the clinical relevance of HLA-G expression in certain pathological conditions, such as infection, oncology, autoimmunity, inflammation and transplantation. The long-term goal of his lab is to understand the physiological function and clinical significance of HLA antigens, in particular the HLA-G molecule, and the molecular mechanisms underlying HLA-involved in various physical and pathological conditions.

Riad AGBARIA is Associate Professor in Department of Clinical Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev Israel

Health Sciences & Clinical Phamacology

Sudha Srivastava National Facility for High Field NMR Tata Institute of Fundamental Research, Mumbai, India

NMR & Spectroscopic Methods

Saumitra Das is Associate Professor in Department of Microbiology Cell Biology, Indian Institute of Science, Sir C V Raman Avenue, Bangalore, India

Ribosome binding to the IRES element has been shown to be mediated by a number of cellular proteins (trans acting factors) and cis acting RNA elements. We are studying the RNA-protein interactions that are critical for viral and cellular IRES function

Dr. Deepak Kaul is the Professor, Head of Experimental Medicine and Biotechnology, Department in Postgraduate Institute of Medical Education Research, Chandigarh, India. He earned his PhD at AIIMS New Delhi. He has published 120 reviewed papers and has teaching experience of more than 30 years. He served as member of New York academy of science, American association of advancement of science. He is currently serving as member of editorial board as well as reviewer of peer reviewed International Journals in the area of Functional Genomics, Genomic Immunity. He has chaired 25 International conferences. He has received many awards honours including the prestigious fellowship of  "Indian National Science Academy". He has served many National International academic bodies especially engaged in Molecular Medicine and Human Genomics. His research interest include functional RNAomics in health and diseased states especially Coronary Heart Disease, Leukemia, AIDS, Tuberculosis

Functional RNA omics of genes responsible for human diseases such as Leukemia; Coronary Heart Disease; Host-susceptibility to M.Tuberculosis and HIV-1 infection

B. Sharma is Professor of Biochemistry, Chairman, Department of Biochemistry Coordinator Centre for Biotechnology, University of Allahabad, India

Biochemistry and Cellular biology

Robin J Green is the Head of the Department of Pediatrics and Child Health at the University of Pretoria, South Africa. He earned his PhD at University of the Witwatersrand, South Africa in 2003. Currently he is the Director of Paediatric Pulmonology Paediatric Critical Care and Paediatric Allergy Services at the Steve Biko Academic Hospital in Pretoria South Africa. He has published 50 Reviewed papers and he was author of 3 book chapters. He has been teaching experience of more than 20 years. He served as Chairman of the National Asthma Education Programme of South Africa. He is an Executive member of the South African Thoracic Society and Allergy society of South Africa. He served as a reviewer of peer reviewed journals in the area of cell pulmonology and allergy. He organized 10 conferences. He received the NAEP Lifetime Service Award

HIV-realted ling disease, Paediatric asthma and allergic rhinitis.

Sung-Jun HAN Institut Pasteur Korea IP Korea Drug Biology Group, Korea

Drug Biology and Drug Metabolism

Dr. Chu obtained his PhD in Medical Virology from the National University of Singapore NUS. Dr Chu was awarded the prestigious Singapore Millennium Foundation Postdoctoral Fellowship in 2006. Subsequently, Dr Chu continued his postdoctoral training at the Harvard Medical School where he has developed a novel high throughput antiviral drugs screening platform for dengue virus In 2007. Dr Chu has received the distinguished Lee Kuan Yew fellowship and the America Society of Microbiology Scientific Achievement Award ICAAC, Young Investigator Award in year 2008. Dr Chu is currently an Assistant Professor in the Department of Microbiology Yong Loo Lin School of Medicine, National University of Singapore. Dr Chua research laboratory is actively engaged in the application of genomewide gene silencing technology molecular virology bioimaging and proteomics techniques to study the interaction between host factors and viral components during virus replication focusing especially on Dengue virus Enteroviruses and Chikugunya virus. By understanding the replication processes of these pathogenic viruses Dr Chu hopes to develop effective antiviral strategies against these viruses Since 2001. Dr Chu has published over 30 international peerreviewed scientific publications book chapters and over 80 conference papers. A number of these scientific papers are published in prestigious journals including Proceedings of the National Academy of Sciences PNAS, Journal of Biological Chemistry, JBC and Journal of Virology. Dr Chu is currently serving as the associate editor and reviewer for a number of peerreviewed journals in area of medical virology and antiviral strategies. Two US patents have also been generated from his current research

RNA virology and Antiviral strategies, Bio-imaging

Dr Sadhna Joshi obtained her PhD and DSc degrees from the University of Paris VII France. She joined the Department of Microbiology at the University of Toronto Canada in 1988, Currently she is Associate Professor in the Department of Molecular Genetics and the Department of Laboratory Medicine and Pathobiology at the University of Toronto, Canada. She has published ~50 articles in refereed journals and has been teaching a course on HIV Gene Therapy since 1997. Her research is focused on HIV gene therapy

Genetic strategies for the prevention and treatment of HIV-1 infections.

Vincent Ho, School of Medicine, James Cook University, Australia

Virology, Biomedical Research

Lul Raka is Assistant Professor of Medical Microbiology Medical School, Prishtina University, Department of Microbiology, National Institute of Public Health of Kosova, Europe.

Medical Microbiology

Dr. Nigel Stevenson is an HRB Fellow in School of Biochemistry and Immunology, Trinity College, Dublin, Ireland. He earned his PhD at Queena University of Belfast N Ireland United Kingdom. He has published in The Journal of Immunology, The Journal of Virology, The Journal of Biological Chemistry, The Journal of Leukocyte Biology and Human Immunology and he was author of a book chapter in "The Role of the Immune System in Cancer Infection in the cancer patient". He is a member of the Irish and British Society of Immunology. He is on the committee of the Irish Society of Immunology. He was an organizer of the "Viruses and Innate Immunity" EMBO workshop 2010 at Trinity College Dublin. Dr Stevenson research examines the molecular and functional aspects of the immune response to viral bacterial and allergic stimuli. His work endeavours to bridge molecular and clinical science applicable to medicine and generation of novel therapeutics

Dr. Stevenson research examines the molecular and functional aspects of the immune response to viral, bacterial and allergic stimuli. His work endeavours to bridge molecular and clinical science applicable to medicine and generation of novel therapeutics

Ludmila Viksna is the professor and chair in Department of infectology and dermatology, The Riga Stradins University Latvia. She earned his PhD at Riga Medical Institute Latvia Currently. She is the head of Tuberculosis and Lung diseases department of state agency Infectology Center of Latvia Corresponding Member and members of expert commissions of Latvian Academy of Sciences. She has published 362 Reviewed papers and she was author of 4 books and 2 books chapters. He has been teaching experience of more than 30 years. She served as president of Infectologists Associations of Latvia and vicepresident of Physicians Society of Latvia. She was one of the members in European Association of Study of the Liver and European society of Clinical microbiology and infectious Diseases. She served as a reviewer of peerreviewed journals in the area of HIV/AIDS infectology. She organized BalticNordic infectologists and hepatologists conferences. She received many awards like diploma of Three Stars order for merits in favor of Latvia; Officer of Three Stars order 3003 2009 and WHO certificate of appreciation

Hepatitis, Tuberculosis and Borreliosis.

Søren Bregenholt is Chief Operating Officer Symphogen A/S Elektrovej Denmark Europe

Pharmacology and Pharmaceutical Sciences

Victorija Calovska Ivanova is Professor of Internal Medicine Chief of Hepatology Unit. She received Best oral presentation 10th UEGW Geneva 2002 and "Chevalier de lOrdre des Palmes academiques" Order of Honor from the French Government 2006 award. She has approximately 80 publications in the country and abroad

Clinical and basic hepatology, Hepatitis

Dr von Hentig currently is Reader of Clinical Pharmacology and Senior House Officer in the Medical Department Infectiology of the Johann Wolfgang Goethe University Hospital Frankfurt am Main, Germany. He earned his MD also at the University of Frankfurt in 2001. He has published more than 30 reviewed papers. He has been teaching experience of more than 8 years and he currently serves as head of the Section Clinical Pharmacology of the German AIDS Society. He is a member of several national and international medical societies such as the ASCPT the IAS the EACS and the German AIDS Society. He served as a reviewer of various peerreviewed journals in the area of infectiology research internal medicine and pharmacology. He is also member in international scientific working groups such as PKPDia and founded himself a Germanywide collaboration of clinics and laboratories involved in the field of clinical pharmacology of antiretroviral therapy, the PKART collaboration 2006, he received the ASCPT Presidential Trainee Award 2006 of the American Society for Clinical Pharmacology and Therapeutics. His working fields mainly are the clinical pharmacology of HIVtherapy focusing on special patient populations HIVtherapy related thrombocyte function and pk/pd modelling.

Infectiology research, Internal medicine & Pharmacology

She received her Chemistry degree and her PhD Degree in Biological Chemistry at the School of Sciences, University of Buenos Aires in Buenos Aires, Argentina/ As a Research Fellow from World Health Organization. She also received postdoctoral training in Virology at the Department of Microbiology, University of Alabama, Birmingham, USA. Currently she is Full Professor of Microbiology and Virology in the Department of Biological Chemistry at School of Sciences, University of Buenos Aires and a Member of the Research Career from the National Research Council Buenos Aires, Argentina. She is coauthor of 110 original articles and 30 review articles and book chapters. She was Supervisor of nine Doctoral Thesis and two Master Thesis at Buenos Aires University. Based on her expertise on arenaviruses she also acted as Member of Expertise Committee for evaluation of preclinical and clinical phases of Candid 1 candidate vaccine for Argentine hemorrhagic fever, Ministry of Health Buenos Aires, Argentina. Additionally, Dr Damonte was Editor in Chief of Revista Argentina de Microbiología Official Publication of Asociaciation Argentina de Microbiología in 1986-2004 and also participated as President of the Organizing Committee of VII Argentine Congress of Virology 2002

Her research interests are focused on the finding of new molecules with therapeutic potential mainly targeted to emerging human viral infections which represent a serious human health problem. Based on our experience on basic investigations, the studies comprise the evaluation and characterization of the antiviral activity against Junin virus, agent of Argentine hemorrhagic fever, dengue virus and herpes simplex virus of novel compounds with different chemical structures, including natural products isolated from marine organisms and plants as well as synthetic compounds. In addition to the impact in the improvement of the therapy for reemerging virus infections, these studies are intended to the knowledge on replication steps of the multiplication cycle of dengue and arenavirus in order to provide clues concerning the molecular targets useful for the development of selective antiviral agents.

Changqing Zeng earned her PhD at the University of Alabama at Birmingham, US. Currently she is the professor in Beijing Institute of Genomics Chinese Academy of Sciences and an adjunct Professor in Beijing Normal University. She has published over 50 peer reviewed papers She has teaching experience of more than 20 years. She served as the coordinator of Chinese HapMap Consortium and the Steering Committee member of the International HapMap Project Also. She is a member of the Expert Panel of the Human Genetic Resources Administration of China. She also served as a reviewer of peerreviewed journals in the area of genomics and HBV research The awards. she received include the CUSBEA scholarship the National Science Fund for Distinguished Young Scholars of the National Natural Science Foundation of China and the Hundred Talents Program of the Chinese Academy of Sciences

Dr. Zeng’s research interests focus on human and HBV genomes. Currently she has several projects including to analyze human genome variations by high throughput sequencing and genotyping, disease gene mapping by association studies, linkage analysis, and exome sequencing, and HBV mutations and the roles of viral mutations in drug resistance and disease progress

Ying-Ray Lee, Department of Biomedical Sciences, Chiayi Christian Hospital, Jhongsiao Road, Chiayi city, Taiwan

Biomedical Sciences

Dr Sunit Kumar Singh has completed his Bachelor degree programme from GB Plant University of Agriculture Technology, Pantnagar and Masters from CIFE Mumbai. After completing the Master degree program Dr Singh moved to Department of Paediatric Rheumatology Immunology and Infectious Diseases, Children laquos Hospital University of Wuerzburg Germany as Biologist. Dr Singh completed his PhD degree from University of Wuerzburg Wuerzburg, Germany in the area of Molecular Infection Biology. Dr Singh has completed his postdoctoral trainings from Departmentt of Internal medicine, Yale University School of Medicine, New Haven Connecticut, USA and Department of Neurology, University of California, Davis Medical Centre Sacramento, California, USA.

Neurobiology & Infectious Diseases, Molecular Infection Biology

Neerja Kaushik-Basu, Ph. D. is an Associate Professor in the Department of Biochemistry and Molecular Biology at the New Jersey Medical School-UMDNJ. She received her Ph.D. in Biochemistry and Molecular Biology from the University of Bombay and did her post-doctoral research at New Jersey Medical School, NJ, USA and Lady Davis Institute for Medical Research, McGill University, Canada. She joined UMDNJ as a faculty in 2001. She has a broad expertise in the field of biochemistry and molecular virology of retroviruses and Hepatitis C virus with focus on their replication, pathogenesis and inhibition mechanisms. She is serving as an editorial board member of three journals and as ad-hoc reviewer of several reputed journals

Viral polymerase structure-function studies, Host-virus interactions during HCV infection, Antiviral mechanisms of small molecule inhibitors of HIV and HCV, Mechanisms of HCV oncogenesis modulated by Rho-RAS pathway effectors

Johan Lennerstrand has received his PhD in Medical Virology in 1996 at Uppsala University, Sweden. He did his postdoctoral work in 1998 – 2000 with Dr Brendan Larder at Virco UK, Cambridge. He became in 2005 an Associate Professor in Experimental Virology at Karolinska Institutet, Stockholm. In 2005 - 2007, Johan Lennerstrand was a visiting scientist in Professor Raymond Schinazi´s laboratory at Emory University, Atlanta. He is currently at Section of Virology, Uppsala University. He has authored more than 30 publications including peer reviewed papers, reviews and patents. He is a member of the HCV DrAG. He is the founder of the bi-annual meeting Nordic Conference of HIV and Hepatitis Drug Resistance and Treatment Strategies.

Drug resistance, treatment strategies and drug discovery in Hepatitis C virus, HIV, Influenza virus, Dengue virus and cancer